BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/6/2019 10:43:10 AM | Browse: 725 | Download: 1046
 |
Received |
|
2019-01-25 00:35 |
|
Peer-Review Started |
|
2019-01-25 09:21 |
|
To Make the First Decision |
|
2019-03-14 00:22 |
|
Return for Revision |
|
2019-03-18 03:28 |
|
Revised |
|
2019-03-21 11:32 |
|
Second Decision |
|
2019-03-26 09:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-03-26 20:44 |
|
Articles in Press |
|
2019-03-26 20:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-04-16 18:34 |
|
Typeset the Manuscript |
|
2019-05-06 04:49 |
|
Publish the Manuscript Online |
|
2019-05-06 10:43 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xue-Bing Shi, Ji-Fa Jiang, Feng-Xiang Jin and Wei Cheng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xue-Bing Shi, MD, Attending Doctor, Department of Hematology and Oncology, Tongling People's Hospital, Bijiashan Road 468, Tongguan District, Tongling 244000, Anhui Province, China. sxbtlph@163.com |
| Key Words |
Chronic myeloid leukemia; JAK2 V617F; BCR-ABL1; Imatinib; Myeloproliferative neoplasm; Case report |
| Core Tip |
The Janus kinase 2 (JAK2) V617F mutation is rare in breakpoint cluster region-Abelson1 (BCR-ABL1) positive chronic myeloid leukemia (CML). We report a female CML patient with JAK2 V617F mutation. This special category of CML patients often have notable thrombocythemia besides typical CML features. The patient achieved complete hematological response following treatment with imatinib for two months. After three months of imatinib treatment, the value of BCR-ABL1 (IS) was 0.143%, however, the JAK2 V617F mutation rate rose from 10% to 15%. |
| Publish Date |
2019-05-06 10:43 |
| Citation |
Shi XB, Jiang JF, Jin FX, Cheng W. Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report. World J Clin Cases 2019; 7(9): 1087-1092 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i9/1087.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i9.1087 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
